Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer

NCT01453153 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage IV Pancreatic Cancer

Interventions

DRUG: Gemcitabine
DRUG: PEGPH20
DRUG: Placebo

Sponsor

Halozyme Therapeutics